These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3029010)

  • 1. Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives.
    Michel-Briand Y; Uccelli V; Laporte JM; Plesiat P
    J Antimicrob Chemother; 1986 Dec; 18(6):667-74. PubMed ID: 3029010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of the maintenance and transfer of antibiotic-resistance plasmids by quinolones].
    Uccelli V; Laporte JM; Michel-Briand Y
    C R Seances Soc Biol Fil; 1985; 179(5):696-9. PubMed ID: 2938699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Elimination of various virulence plasmids by antibiotics].
    Michel-Briand Y; Laporte JM; Dupont MJ; Couetdic G
    Pathol Biol (Paris); 1988 Feb; 36(2):159-62. PubMed ID: 3279385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of 4-quinolones and antibiotics in the elimination of virulence plasmids of Enterobacteriaceae].
    Michel-Briand Y; Laporte JM; Plesiat P; Sansonetti PJ
    Pathol Biol (Paris); 1987 Dec; 35(10 Pt 2):1386-8. PubMed ID: 3325901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of a virulence plasmid from Shigella sonnei and Escherichia coli by antibiotics.
    Michel-Briand Y; Laporte JM; Couetdic G; Sansonetti PJ
    Ann Inst Pasteur Microbiol; 1986; 137B(3):291-5. PubMed ID: 3318870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
    Barry AL; Jones RN
    Antimicrob Agents Chemother; 1984 Jun; 25(6):775-7. PubMed ID: 6234858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of antibiotic-resistant plasmids by quinolone antibiotics.
    Fu KP; Grace ME; Hsiao CL; Hung PP
    Chemotherapy; 1988; 34(5):415-8. PubMed ID: 3141117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of plasmids by new 4-quinolones.
    Weisser J; Wiedemann B
    Antimicrob Agents Chemother; 1985 Nov; 28(5):700-2. PubMed ID: 3911881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolones in vitro.
    Willems FT
    Pharm Weekbl Sci; 1986 Feb; 8(1):26-8. PubMed ID: 3960690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of plasmid pMG110 from Escherichia coli by novobiocin and other inhibitors of DNA gyrase.
    Hooper DC; Wolfson JS; McHugh GL; Swartz MD; Tung C; Swartz MN
    Antimicrob Agents Chemother; 1984 May; 25(5):586-90. PubMed ID: 6329090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
    Tabary X; Moreau N; Dureuil C; Le Goffic F
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1925-8. PubMed ID: 2830840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
    Cantet P; Renaudin H; Quentin C; Bebear C
    Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].
    Thabaut A; Durosoir JL
    Pathol Biol (Paris); 1982 Jun; 30(6):394-7. PubMed ID: 6810283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid "curing" by some recently synthetized 4-quinolone compounds.
    Selan L; Scazzocchio F; Oliva B; Schippa S; Allocati N; Renzini G
    Chemioterapia; 1988 Oct; 7(5):292-4. PubMed ID: 3066515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.